COMMUNIQUÉS West-GlobeNewswire

Avinger Regains Compliance with Nasdaq Listing Requirements

02/03/2018 - 14:00

REDWOOD CITY, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced it has regained compliance with [...]

Fluidigm Announces Exchange of Convertible Notes

02/03/2018 - 13:45

SOUTH SAN FRANCISCO, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that it has entered into separate privately negotiated transactions to exchange approximately $125.0 [...]

Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2017 Financial and Operating Results

02/03/2018 - 13:30

ADVANCED TWO PROGRAMS INTO PIVOTAL TRIALS IN 2017 CARDINAL PHASE 2 RETAINED BENEFIT DATA EXPECTED 3Q18 DATA FROM FIRST PHOENIX COHORT EXPECTED 2H18 IRVING, Texas, March 02, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals [...]

TG Therapeutics, Inc. to Present at Upcoming Investor Conferences

02/03/2018 - 13:30

NEW YORK, March 02, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will be presenting at two upcoming [...]

Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting

02/03/2018 - 13:23

Shareholders approve 21 st consecutive dividend increase to CHF 2.80 (+2%) per share for 2017; representing a 3.6% yield and approximately 67% payout of free cash flow Dr. Joerg Reinhardt confirmed by shareholders as [...]

Les actionnaires de Novartis approuvent toutes les résolutions proposées par le Conseil d'administration lors de l'Assemblée générale

02/03/2018 - 13:23

Les actionnaires approuvent la 21 e hausse consécutive du dividende, à CHF 2,80 (+2 %) par action au titre de l'exercice 2017, soit un rendement de 3,6 % et une distribution du free cash-flow d'environ 67 %. Le Dr Joerg [...]

ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018

02/03/2018 - 13:01

Geneva, Switzerland and Boston, MA - March 2, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Calithera Biosciences to Report Fourth Quarter 2017 Financial Results on Thursday, March 8, 2018

02/03/2018 - 13:00

SOUTH SAN FRANCISCO, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs [...]

TearLab Corporation Reports Fourth Quarter and Full Year 2017 Financial Results

02/03/2018 - 13:00

SAN DIEGO, March 02, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended [...]

Melinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care Conference

02/03/2018 - 13:00

NEW HAVEN, Conn., March 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage pharmaceutical company developing and commercializing novel antibiotics to treat serious bacterial [...]

Cannabis Wheaton Income Corp. Announces Filing of Amended and Restated Final Base Shelf Prospectus

02/03/2018 - 13:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis [...]

BIONOVELUS C.I.O.DEPARTURE

02/03/2018 - 13:00

FOR IMMEDIATE RELEASE / Phoenix, March 02, 2018 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (ONOV), whose CR-10® Biofungicide is a non-toxic solution for safe and effective pre- and post-harvest applications, is announcing [...]

Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax Technologies

02/03/2018 - 12:30

BERKELEY, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (“Dynavax”) (NASDAQ: DVAX ) announced today that Stanley A. Plotkin, M.D. has indicated his intention to step down from the Board of [...]

ChromaDex Sets Fourth Quarter and Full Year 2017 Conference Call for Thursday, March 8, 2018 at 4:30 p.m. ET

02/03/2018 - 12:30

IRVINE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, will hold a [...]

Orion Corporation: Managers' transactions - Olli Huotari

02/03/2018 - 08:46

ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]

Orion Corporation: Managers' transactions - Timo Lappalainen

02/03/2018 - 08:46

ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation [...]

Orion Corporation: Managers' transactions - Virve Laitinen

02/03/2018 - 08:46

ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]

Orion Corporation: Managers' transactions - Satu Ahomäki

02/03/2018 - 08:46

ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]

Orion Corporation: Managers' transactions - Markku Huhta-Koivisto

02/03/2018 - 08:46

ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Markku Huhta-Koivisto Orion Corporation has received the following disclosure under Market Abuse [...]